blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3441466

EP3441466 - METHOD FOR PRODUCING A NOVEL RECOMBINANT FACTOR C, METHOD FOR MITIGATING REACTION INHIBITION IN ENDOTOXIN ASSAYS, AND METHOD FOR MEASURING ENDOTOXIN [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  03.01.2020
Database last updated on 24.08.2024
FormerGrant of patent is intended
Status updated on  12.08.2019
FormerExamination is in progress
Status updated on  12.03.2019
FormerRequest for examination was made
Status updated on  22.02.2019
FormerThe application has been published
Status updated on  11.01.2019
Most recent event   Tooltip10.07.2024New entry: Decision (+date) in appeal procedure 
10.07.2024Deletion: Date of oral proceedings 
Applicant(s)For all designated states
Seikagaku Corporation
6-1, Marunouchi 1-chome
Chiyoda-ku
Tokyo 100-0005 / JP
[2019/07]
Inventor(s)01 / MIZUMURA, Hikaru
c/o SEIKAGAKU CORPORATION Central Research
Laboratories, 1253, Tateno 3-chome
Higashiyamoto-shi
Tokyo, 207-0021 / JP
02 / ODA, Toshio
c/o SEIKAGAKU CORPORATION Central Research
Laboratories, 1253, Tateno 3-chome
Higashiyamoto-shi
Tokyo, 207-0021 / JP
03 / KAWABATA, Shun-ichiro
c/o KYUSHU UNIVERSITY
6-10-1 Hakozaki, Higashi-ku, Fukuoka-shi
Fukuoka, 812-8581 / JP
 [2019/07]
Representative(s)Müller-Boré & Partner Patentanwälte PartG mbB
Friedenheimer Brücke 21
80639 München / DE
[2019/07]
Application number, filing date18190686.810.12.2013
[2019/07]
Priority number, dateJP2012026984010.12.2012         Original published format: JP 2012269840
[2019/07]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3441466
Date:13.02.2019
Language:EN
[2019/07]
Type: B1 Patent specification 
No.:EP3441466
Date:05.02.2020
Language:EN
[2020/06]
Search report(s)(Supplementary) European search report - dispatched on:EP10.01.2019
ClassificationIPC:C12N15/09, C12N9/64, C12P21/02, C12Q1/37, G01N33/569, G01N33/579
[2019/07]
CPC:
C12N9/6408 (EP,US); C12Y304/21069 (EP,US); C12Y304/21084 (EP,US);
G01N33/56911 (EP,US); G01N33/579 (EP,US); G01N2333/96411 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/13]
Former [2019/07]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:VERFAHREN ZUR HERSTELLUNG EINES NEUARTIGEN REKOMBINANTEN FAKTORS C, VERFAHREN ZUR VERMINDERUNG DER REAKTIONSHEMMUNG IN ENDOTOXIN-ASSAYS UND VERFAHREN ZUR MESSUNG VON ENDOTOXIN[2019/07]
English:METHOD FOR PRODUCING A NOVEL RECOMBINANT FACTOR C, METHOD FOR MITIGATING REACTION INHIBITION IN ENDOTOXIN ASSAYS, AND METHOD FOR MEASURING ENDOTOXIN[2019/07]
French:PROCÉDÉ DE PRODUCTION D'UN NOUVEAU FACTEUR C DE RECOMBINAISON, PROCÉDÉ PERMETTANT D'ATTÉNUER L'INHIBITION DE RÉACTION DANS DES DOSAGES D'ENDOTOXINE ET PROCÉDÉ DE MESURE D'ENDOTOXINE[2019/07]
Examination procedure07.02.2019Amendment by applicant (claims and/or description)
14.02.2019Examination requested  [2019/13]
14.02.2019Date on which the examining division has become responsible
15.03.2019Despatch of a communication from the examining division (Time limit: M04)
08.05.2019Reply to a communication from the examining division
13.08.2019Communication of intention to grant the patent
02.12.2019Receipt of the translation of the claim(s)
05.12.2019Fee for grant paid
05.12.2019Fee for publishing/printing paid
Parent application(s)   TooltipEP13862466.3  / EP2930241
Divisional application(s)EP19216609.8  / EP3663400
EP22215393.4  / EP4219705
Opposition(s)Opponent(s)01  05.11.2020  09.11.2020  ADMISSIBLE
Pohlman, Sandra M.
df-mp Dörries Frank-Molnia & Pohlman
Patentanwälte Rechtsanwälte PartG mbB
Fünf Höfe
Theatinerstraße 16
80333 München / DE
Opponent's representative
Pohlman, Sandra M.
df-mp Dörries Frank-Molnia & Pohlman
Patentanwälte Rechtsanwälte PartG mbB
Theatinerstrasse 16
80333 München / DE
 [2020/51]
19.11.2020Invitation to proprietor to file observations on the notice of opposition
18.03.2021Reply of patent proprietor to notice(s) of opposition
04.10.2022Date of oral proceedings
26.10.2022Despatch of minutes of oral proceedings
26.10.2022Despatch of communication that the patent will be revoked
Appeal following opposition22.12.2022Appeal received No.  T0012/23
22.12.2022Payment of appeal fee
24.02.2023Statement of grounds filed
10.07.2024Result of appeal procedure: appeal of the proprietor withdrawn
Fees paidRenewal fee
30.08.2018Renewal fee patent year 03
30.08.2018Renewal fee patent year 04
30.08.2018Renewal fee patent year 05
17.12.2018Renewal fee patent year 06
18.12.2019Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU10.12.2013
AL05.02.2020
AT05.02.2020
CY05.02.2020
CZ05.02.2020
DK05.02.2020
EE05.02.2020
FI05.02.2020
HR05.02.2020
LT05.02.2020
LV05.02.2020
MC05.02.2020
MK05.02.2020
MT05.02.2020
NL05.02.2020
PL05.02.2020
RO05.02.2020
RS05.02.2020
SE05.02.2020
SI05.02.2020
SK05.02.2020
SM05.02.2020
TR05.02.2020
BG05.05.2020
NO05.05.2020
GR06.05.2020
IS05.06.2020
PT28.06.2020
LU10.12.2020
[2022/31]
Former [2022/30]HU10.12.2013
AL05.02.2020
AT05.02.2020
CY05.02.2020
CZ05.02.2020
DK05.02.2020
EE05.02.2020
FI05.02.2020
HR05.02.2020
LT05.02.2020
LV05.02.2020
MC05.02.2020
MT05.02.2020
NL05.02.2020
PL05.02.2020
RO05.02.2020
RS05.02.2020
SE05.02.2020
SI05.02.2020
SK05.02.2020
SM05.02.2020
TR05.02.2020
BG05.05.2020
NO05.05.2020
GR06.05.2020
IS05.06.2020
PT28.06.2020
LU10.12.2020
Former [2022/27]HU10.12.2013
AT05.02.2020
CY05.02.2020
CZ05.02.2020
DK05.02.2020
EE05.02.2020
FI05.02.2020
HR05.02.2020
LT05.02.2020
LV05.02.2020
MC05.02.2020
MT05.02.2020
NL05.02.2020
PL05.02.2020
RO05.02.2020
RS05.02.2020
SE05.02.2020
SI05.02.2020
SK05.02.2020
SM05.02.2020
TR05.02.2020
BG05.05.2020
NO05.05.2020
GR06.05.2020
IS05.06.2020
PT28.06.2020
LU10.12.2020
Former [2021/47]AT05.02.2020
CZ05.02.2020
DK05.02.2020
EE05.02.2020
FI05.02.2020
HR05.02.2020
LT05.02.2020
LV05.02.2020
MC05.02.2020
NL05.02.2020
PL05.02.2020
RO05.02.2020
RS05.02.2020
SE05.02.2020
SI05.02.2020
SK05.02.2020
SM05.02.2020
BG05.05.2020
NO05.05.2020
GR06.05.2020
IS05.06.2020
PT28.06.2020
LU10.12.2020
Former [2021/40]AT05.02.2020
CZ05.02.2020
DK05.02.2020
EE05.02.2020
FI05.02.2020
HR05.02.2020
LT05.02.2020
LV05.02.2020
MC05.02.2020
NL05.02.2020
PL05.02.2020
RO05.02.2020
RS05.02.2020
SE05.02.2020
SI05.02.2020
SK05.02.2020
SM05.02.2020
BG05.05.2020
NO05.05.2020
GR06.05.2020
IS05.06.2020
PT28.06.2020
Former [2021/11]AT05.02.2020
CZ05.02.2020
DK05.02.2020
EE05.02.2020
FI05.02.2020
HR05.02.2020
LT05.02.2020
LV05.02.2020
NL05.02.2020
PL05.02.2020
RO05.02.2020
RS05.02.2020
SE05.02.2020
SI05.02.2020
SK05.02.2020
SM05.02.2020
BG05.05.2020
NO05.05.2020
GR06.05.2020
IS05.06.2020
PT28.06.2020
Former [2020/50]CZ05.02.2020
DK05.02.2020
EE05.02.2020
FI05.02.2020
HR05.02.2020
LT05.02.2020
LV05.02.2020
NL05.02.2020
RO05.02.2020
RS05.02.2020
SE05.02.2020
SK05.02.2020
SM05.02.2020
BG05.05.2020
NO05.05.2020
GR06.05.2020
IS05.06.2020
PT28.06.2020
Former [2020/49]CZ05.02.2020
DK05.02.2020
FI05.02.2020
HR05.02.2020
LT05.02.2020
LV05.02.2020
NL05.02.2020
RO05.02.2020
RS05.02.2020
SE05.02.2020
SK05.02.2020
SM05.02.2020
BG05.05.2020
NO05.05.2020
GR06.05.2020
IS05.06.2020
PT28.06.2020
Former [2020/48]DK05.02.2020
FI05.02.2020
HR05.02.2020
LT05.02.2020
LV05.02.2020
NL05.02.2020
RO05.02.2020
RS05.02.2020
SE05.02.2020
SM05.02.2020
BG05.05.2020
NO05.05.2020
GR06.05.2020
IS05.06.2020
PT28.06.2020
Former [2020/47]DK05.02.2020
FI05.02.2020
HR05.02.2020
LT05.02.2020
LV05.02.2020
NL05.02.2020
RS05.02.2020
SE05.02.2020
BG05.05.2020
NO05.05.2020
GR06.05.2020
IS05.06.2020
PT28.06.2020
Former [2020/45]FI05.02.2020
HR05.02.2020
LV05.02.2020
NL05.02.2020
RS05.02.2020
SE05.02.2020
BG05.05.2020
NO05.05.2020
GR06.05.2020
IS05.06.2020
PT28.06.2020
Former [2020/40]FI05.02.2020
HR05.02.2020
LV05.02.2020
RS05.02.2020
SE05.02.2020
BG05.05.2020
NO05.05.2020
GR06.05.2020
IS05.06.2020
PT28.06.2020
Former [2020/39]FI05.02.2020
HR05.02.2020
LV05.02.2020
RS05.02.2020
SE05.02.2020
BG05.05.2020
NO05.05.2020
GR06.05.2020
PT28.06.2020
Former [2020/38]FI05.02.2020
HR05.02.2020
LV05.02.2020
RS05.02.2020
SE05.02.2020
NO05.05.2020
GR06.05.2020
PT28.06.2020
Former [2020/37]FI05.02.2020
HR05.02.2020
LV05.02.2020
RS05.02.2020
SE05.02.2020
NO05.05.2020
PT28.06.2020
Former [2020/35]FI05.02.2020
NO05.05.2020
Documents cited:Search[A]WO9915676  (UNIV SINGAPORE [SG]) [A] 1-14 * example -; claim -; sequence 4 *;
 [A]EP2050820  (SEIKAGAKU KOGYO CO LTD [JP]) [A] 1-14 * the whole document *;
 [A]WO2012118226  (SEIKAGAKU KOGYO CO LTD [JP], et al) [A] 1-14 * example -; claim - *;
 [A]  - DING JEAK LING ET AL, Chapter 9: Endotoxin Detection - from Limulus Amebocyte Lysate to Recombinant Factor C, ENDOTOXINS: STRUCTURE, FUNCTION AND RECOGNITION - SERIES : SUBCELLULAR BIOCHEMISTRY IN: SUBCELLULAR BIOCHEMISTRY : REVIEWS AND ESSAYS DEALING WITH THE FUNCTION, GENETICS, BIOGENESIS AND EVOLUTION OF SUB-CELLULAR COMPONENTS, ISSN 0096-8757 ; VOL. 53;, (20100101), ISBN 978-90-481-9077-5, XP009510157 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1007/978-90-481-9078-2_9
 [A]  - DWARAKANATH ROOPASHREE S ET AL, "Recombinant COS-1 cells express Carcinoscorpius rotundicauda factor C", BIOTECHNOLOGY LETTERS, (199704), vol. 19, no. 4, ISSN 0141-5492, pages 357 - 361, XP002787576 [A] 1-14 * page 359, column r, paragraph 2 * * page 360, column r, paragraph 1 *

DOI:   http://dx.doi.org/10.1023/A:1018307118879
 [T]  - HIRAKU MIZUMURA ET AL, "Genetic engineering approach to develop next-generation reagents for endotoxin quantificationin Cos-1", INNATE IMMUNITY, (201702), vol. 23, no. 2, doi:10.1177/1753425916681074, pages 136 - 146, XP002787577

DOI:   http://dx.doi.org/10.1177/1753425916681074
by applicantUS5712144
 WO2008004674
 WO2012118226
    - IWANAGA S., Curr. Opin. Immunol., (19930200), vol. 5, no. 1, pages 74 - 82
    - NAKAMURA T. et al., J. Biochem., (19860300), vol. 99, no. 3, pages 847 - 57
    - ROOPASHREE S. DWARAKANATH et al., Biotechnology letters, (19970000), vol. 19, no. 4, pages 357 - 361
    - JING WANG; BOW HO; JEAK L. DING, Biotechnology letters, (20010000), vol. 23, pages 71 - 76
    - MAKOTO TAKEDA et al., J. Viol., (20050000), vol. 79, no. 22, pages 14346 - 54
    - MIYATA et al., Protein Nucleic acid Enzyme, (19860000), pages 30 - 43
    - YOSHIKI MIURA et al., J. Biochem., (19920000), vol. 112, pages 476 - 481
    - HASHIGUTI et al., "Expression of Recombinant Protein Using Cultured Human Cells -Standard Protocol by 293-type cells", PSSJ Archives, vol. 1, (20080000), page e017, URL: http://www.pssj.jp/archives/Protocol/Expression/293_01/293_01 _01.html
    - TAKANORI NAKAMURA et al., Eur. J. Biochem., (19860000), vol. 154, pages 511 - 521
    - JEAK L. DING et al., Biochem. Biophys. Acta, vol. 1202, pages 149 - 156
    - JEAK L. DING et al., Biochem. Biophys. Acta, (19930000), vol. 1202, pages 149 - 156
    - JING WANG et al., J. Biol. Chem., (20020000), vol. 277, no. 39, pages 36363 - 72
    - ROBERT L. HARRISON; DONALD L. JARVIS, Methods in Molecular Biology, (20070000), vol. 338, pages 341 - 356
OppositionUS5858706
 US6645724
    - WANG, JING et al., "Modular Arrangement and Secretion of a Multidomain Serine Protease- Evidence for involvement of proline-rich region and N-glycans in the secretion pathway", J. Biol. Chem., (20020000), vol. 277, no. 39, pages 36363 - 36372, XP055752086

DOI:   http://dx.doi.org/10.1074/jbc.M202837200
    - CARLESSO, E. et al., "The rule regulating pH changes during crystalloid infusion", Intensive Care Med., (20110000), vol. 37, no. 3, doi:10.1007/s00134-010-2095-y, pages 461 - 468, XP019884376

DOI:   http://dx.doi.org/10.1007/s00134-010-2095-y
    - "Blood Plasma", Wikipedia, (20121114), URL: https://en.wikipedia.org/w/index.php?title=Blood_plasma&oldid=522988091, XP055752087
    - "Horseshoe Crab", Wikipedia, (20111117), URL: https://en.wikipedia.org/w/index.php?title=Horseshoe_crab&oldid=461115477, XP05575209
    - DING, JEAK L. et al., "A new era in pyrogen testing", TRENDS in Biotech., (20010000), vol. 19, no. 8, doi:10.1016/S0167-7799(01)01694-8, pages 277 - 281, XP004254274

DOI:   http://dx.doi.org/10.1016/S0167-7799(01)01694-8
    - HARADA-SUZUKI, T. et al., "Further Studies on the Chromogenic Substrate Assay Method for Bacterial Endotoxins Using Horseshoe Crab (Tachypleus tridentatus) Hemocyte Lysate", J. Biochem., (19820000), vol. 92, no. 3, pages 793 - 800, XP055752099

DOI:   http://dx.doi.org/10.1093/oxfordjournals.jbchem.a133991
    - TOMIYA, N. et al., "Comparing N-glycan processing in mammalian cell lines to native and engineered lepidopteran insect cell lines", Glycoconjugate Journal, (20040000), vol. 21, doi:10.1023/B:GLYC.0000046275.28315.87, pages 343 - 360, XP019207025

DOI:   http://dx.doi.org/10.1023/B:GLYC.0000046275.28315.87
    - Joanne E. Nettleship, "Chapter 3 - Structural Biology of Glycoproteins", Glycosylation, (2012), pages 41 - 62, XP055752108
    - HOSSLER, P . et al., "Optimal and consistent protein glycosylation in mammalian cell culture", Gycobiol, vol. 19, no. 9, doi:10.1093/glycob/cwp079, pages 936 - 949, XP055112498

DOI:   http://dx.doi.org/10.1093/glycob/cwp079
    - THOMAS, P. et al., "HEK293 cell line: A vehicle for the expression of recombinant proteins", J. Pharmacol. And Toxicol. Methods, (20050000), vol. 51, doi:10.1016/j.vascn.2004.08.014, pages 187 - 200, XP004873792

DOI:   http://dx.doi.org/10.1016/j.vascn.2004.08.014
    - KOSHIBA, T. et al., "A Structural Perspective on the Interaction between Lipopolysaccharide and Factor C, a Receptor Involved in Recognition of Gram-negative Bacteria", J. Biol. Chem, (20070000), vol. 282, no. 6, doi:10.1074/jbc.M609198200, pages 3962 - 3967, XP055530584

DOI:   http://dx.doi.org/10.1074/jbc.M609198200
    - KINGSTON, R. E. et al., "Amplification Using CHO Cell Expression Vectors", Current Protocols in Molecular Biology, (19930000), vol. Unit 16.23, no. suppl. 60, pages 16.23.1 - 16.23.13, XP055752113

DOI:   http://dx.doi.org/10.1002/0471142727.mb1623s60
    - ALBERTS et al., ESSENTIAL CELL BIOLOGY, 2nd ed., New York and London, (20040000), page 209, XP055752117
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.